Company Filing History:
Years Active: 2014-2025
Title: Innovator Profile: Laura Das – Pioneering Pharmaceutical Advancements
Introduction: Laura Das, a prominent inventor based in Charlestown, MA, has made significant contributions to the field of pharmaceuticals. With a total of five patents to her name, her work showcases a commitment to innovation and the advancement of medical treatments, particularly for conditions such as cystic fibrosis.
Latest Patents: Among her latest innovations is a patent for a pharmaceutical composition that includes a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide. This invention details formulations of solid dispersions into powders, granules, and mini-tablets. It also outlines methods for manufacturing and processing these formulations, as well as applications for treating cystic fibrosis. This focus on developing effective pharmaceutical compositions underscores her dedication to improving patient outcomes.
Career Highlights: Laura Das is currently associated with Vertex Pharmaceuticals, Inc., a leading company in the biopharmaceutical sector focused on the development of innovative medicines. Within her role, she has further honed her expertise in pharmaceutical development and has played an essential part in advancing various projects aligned with the company's mission.
Collaborations: Throughout her career, Laura has worked alongside noteworthy colleagues, including Eleni Dokou and Shahla Jamzad. Their collaborations reflect a strong network of professionals dedicated to pioneering advancements in medicine and enhancing the effectiveness of pharmaceutical treatments.
Conclusion: Laura Das exemplifies the spirit of innovation within the pharmaceutical industry. Her patents, particularly those targeting cystic fibrosis, have the potential to make a significant impact on patient care. As she continues her work with Vertex Pharmaceuticals, her contributions are sure to influence the landscape of pharmaceutical development for years to come.